MTOR and Alzheimer disease: Inhibitors of PI3K/mTOR, such as dactolisib (BEZ235) and GNE-477, exemplify this class by effectively dampening microglial cytokine expression and amyloid deposition in AD models but are hampered by toxicity and immunosuppression [64].